Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: AZA-QUINOLINE COMPOUNDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: Pharmaceutical Combinations Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: NEW CRYSTALLINE FORMS OF N-(3-(2-(2-HYDROXYETHOXY)-6-MORPHOLINOPYRIDIN-4-YL)-4-METHVLPHENYL)-2 (TRIFLUOROMETHYL)ISONICOTINAMIDE AS RAF INHIBITORS FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: NLRP MODULATORS Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: MEDICAL CONTAINER WITH NFC ANTENNA Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: TREATMENT COMPRISING SGLT INHIBITORS Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: CELL BAG ROTATOR Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: RAPAMYCIN DERIVATIVES Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: SYSTEMS AND METHODS FOR USER VERIFICATION BASED ON ACTIGRAPHY DATA Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: Pharmaceutical Composition Filling date: 23 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: INTERMITTENT DOSING OF MDM2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Filling date: 23 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: Constitutive Yeast LLP Promotor-Based Expression Systems Filling date: 23 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS Filling date: 23 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: COMMUNICATION MODULE FOR AN AUTOINJECTOR Filling date: 23 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: BCL-2 INHIBITORS FOR USE IN THE TREATMENT OF A BCL-2 MEDIATED CANCER CARRYING THE GLY101VAL MUTATION Filling date: 23 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES Filling date: 23 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METHODS FOR PRODUCING A PHARMACEUTICAL CARRIER Filling date: 23 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMYCIN DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METHODS FOR TREATING OCULAR SURFACE PAIN Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: COMBINATION THERAPY FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: CRYSTALLINE FORMS OF N-(5-(5-((1R,2S)-2-FLUOROCYCLOPROPYL)-1,2,4-OXADIAZOL-3-YL)-2-METHYLPHENY- L)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF TIDM AND INSULITIS Filling date: 23 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: USE OF A H3R INVERSE AGONIST FOR THE TREATMENT OF SHIFT WORK DISORDER Filling date: 23 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3 Filling date: 23 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: COMBINATION THERAPY Filling date: 23 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING A BRUTON'S TYROSINE KINASE INHIBITOR Filling date: 23 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: NOVEL DIAMINO PYRIDINE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: USE OF THE IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVIATING SYMPTOMS OF PULMONARY SARCOIDOSIS Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS OF A SELECTIVE C-KIT KINASE INHIBITOR AND METHODS FOR MAKING AND USING SAME Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: Bispecific Antibodies for use in treatment of NLRC4-GOF inflammasomapathy Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: METHODS OF TREATING SJOGREN'S SYNDROME USING A BRUTON'S TYROSINE KINASE INHIBITOR Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: DIGITAL SOLUTIONS FOR DIFFERENTIATING ASTHMA FROM COPD Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Showing 1 to 50 of 676 patents.